PMAM
JSPRW

Picton Mahoney Asset Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Picton Mahoney Asset Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-187,500
Closed -$153K – 894
2021
Q1 		$153K Hold
187,500
– – 0.01% 295
2020
Q4 		$272K Hold
187,500
– – 0.01% 284
2020
Q3 		$221K Hold
187,500
– – 0.01% 286
2020
Q2 		$192K Hold
187,500
– – 0.01% 261
2020
Q1 		$122K Buy
+187,500
New +$147K 0.01% 266

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $244M AUM 110.95% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return

Picton Mahoney Asset Management's JSPRW Position: Q2 2021 in Review

Picton Mahoney Asset Management sold out of Japer Therapeutics Warrants (JSPRW) in Q2 2021, closing a stake of 187,500 shares — an estimated $153K sold.

Picton Mahoney Asset Management first reported a position in JSPRW in Q1 2020 and held it in 5 quarters. The position peaked at $272K in Q4 2020. 21 funds tracked by Wall St. Rank hold JSPRW as of Q2 2021.

  • Picton Mahoney Asset Management reported no remaining Japer Therapeutics Warrants position as of Q2 2021 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 187,500 Japer Therapeutics Warrants shares in Q2 2021, an estimated $153K.
  • Picton Mahoney Asset Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 5 quarters.
  • Picton Mahoney Asset Management's Japer Therapeutics Warrants position peaked at $272K in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.